Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Gross Margin (2020 - 2025)

Biofrontera (BFRI) has 5 years of Gross Margin data on record, last reported at 70.74% in Q3 2025.

  • For Q3 2025, Gross Margin fell 2842.0% year-over-year to 70.74%; the TTM value through Sep 2025 reached 64.41%, up 2299.0%, while the annual FY2024 figure was 50.14%, 134.0% up from the prior year.
  • Gross Margin reached 70.74% in Q3 2025 per BFRI's latest filing, roughly flat from 70.74% in the prior quarter.
  • Across five years, Gross Margin topped out at 99.62% in Q2 2022 and bottomed at 72.27% in Q4 2022.
  • Average Gross Margin over 5 years is 68.05%, with a median of 96.56% recorded in 2021.
  • Peak YoY movement for Gross Margin: crashed -17030bps in 2022, then skyrocketed 7295bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 98.03% in 2021, then crashed by -174bps to 72.27% in 2022, then surged by 79bps to 14.92% in 2023, then soared by 489bps to 58.03% in 2024, then increased by 22bps to 70.74% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 70.74% in Q3 2025, 70.74% in Q2 2025, and 61.95% in Q1 2025.